Jessica M McDaniel

Title: The Innovative Contributions of Jessica M McDaniel

Introduction

Jessica M McDaniel is an accomplished inventor based in Etna, Ohio. She has made significant strides in the field of cancer treatment through her innovative research and patent contributions. Her work focuses on the immune modulation of cancer therapies, particularly involving the drug lenalidomide.

Latest Patents

Jessica holds a patent titled "CD28 expression during lenalidomide immune modulation." This patent discloses compositions and methods for predicting a subject's responsiveness to treatment with lenalidomide by assaying a sample for surface expression of CD28 on T-cells. The patent also outlines a method for treating cancer by assessing CD28 surface expression and administering lenalidomide accordingly. Furthermore, it provides a method for enhancing responsiveness to lenalidomide by promoting CD28 expression on T-cells.

Career Highlights

Jessica is affiliated with the H. Lee Moffitt Cancer Center and Research Institute, Inc., where she contributes her expertise in cancer research and treatment. Her work has been instrumental in advancing the understanding of immune responses in cancer therapy.

Collaborations

Jessica collaborates with Pearlie Burnette, a fellow researcher, to further explore the implications of their findings in cancer treatment. Their partnership exemplifies the importance of teamwork in scientific research.

Conclusion

Jessica M McDaniel's innovative work in cancer treatment through her patent on CD28 expression highlights her significant contributions to the field. Her research continues to pave the way for improved therapeutic strategies in oncology.